Sexually Transmitted Infections

A new oral antibiotic called zoliflodacin has shown effectiveness in treating gonorrhoea, clearing 91 percent of infections in a clinical trial. The drug offers a potential alternative to the increasingly resistant standard treatment of ceftriaxone. With resistance to existing antibiotics rising globally, this development could help delay the emergence of untreatable strains.